Clinical Trial Update: A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities. [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates PROCRIT (epoetin alfa) for treating anemia in adults with chronic kidney disease living in long-term care facilitie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Renal Failure , Chronic, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2013-05-13